<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03849079</url>
  </required_header>
  <id_info>
    <org_study_id>UF 7542</org_study_id>
    <nct_id>NCT03849079</nct_id>
  </id_info>
  <brief_title>Validation of the HYPONUT Product</brief_title>
  <official_title>Clinical Validation of the Inactivation Procedure for Peanut Major Allergens in the HYPONUT Product</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HYPONUT product was previously validated in a laboratory setting (&quot;Procédé de préparation&#xD;
      d'aliment hypoallergénique&quot;, n° FR1250977) on 2012. A international patent was then obtained&#xD;
      on 2013. Through the present study, the investigators would like to prove that the&#xD;
      hypoallergenicity of the product is sustained in a clinical setting. Patients allergic to&#xD;
      peanuts currently undergo in vivo tests to confirm their allergy: skin prick tests, and oral&#xD;
      food challenges. In vitro tests are also performed (i.e. IgE levels for peanut and peanut&#xD;
      components). The follow-up of patients consists in regular yearly or semestral evaluations.&#xD;
      During one of these evaluation, the investigators will skin tests patients with the hyponut&#xD;
      product to verify if they are sensitized to this last one as well. When skin tests will be&#xD;
      negative, the investigators will propose to patients to take some of the product to verify&#xD;
      its tolerability as well.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    All prick tests are positive&#xD;
  </why_stopped>
  <start_date type="Actual">September 24, 2019</start_date>
  <completion_date type="Actual">February 4, 2020</completion_date>
  <primary_completion_date type="Actual">February 4, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Prick Tests evaluation</measure>
    <time_frame>day patient enrolled</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral food challenge evaluation</measure>
    <time_frame>day patient enrolled</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Peanut Allergy</condition>
  <arm_group>
    <arm_group_label>Hyponut</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyponut</intervention_name>
    <description>Prick tests with hyponut</description>
    <arm_group_label>Hyponut</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients aged more than 6&#xD;
&#xD;
          -  Patients suffering from peanut allergy and followed in the Allergy Unit of the&#xD;
             University Hospital of Montpellier (France)&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Pregnancy, or patients breast-feeding&#xD;
&#xD;
          -  Patients treated with drugs possibly altering the results of the tests (e.g.&#xD;
             anti-histamines)&#xD;
&#xD;
          -  Patients presenting with dermographism&#xD;
&#xD;
          -  Patients not fluent in French&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peanut Allergy</keyword>
  <keyword>Skin Prick Test</keyword>
  <keyword>Oral Food Challenge</keyword>
  <keyword>Hyponut</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peanut Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

